{"title": "VIVOWeill Cornell Medical College", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-01-01", "cleaned_text": "Vaccine Journal Overview publication venue for - [Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes.](/display/pubid37117057) 2023 - [Factors impacting parental uptake of COVID-19 vaccination for U.S. Children ages 5-17.](/display/pubid37045680). 41. 2023 - [Cost-effectiveness of pneumococcal vaccines among adults aged 65 years and older in China: A comparative study.](/display/pubid36522264). 41. 2022 - [Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses.](/display/pubid36517323) 2022 - [Immunogenicity culture-based inactivated non-adjuvanted hesitancy and its determinants among elderly in China: A national cross-sectional study.](/display/pubid35788295). 40. 2022 - [Kinetics of pneumococcal antibodies among HIV-exposed, infants in Botswana.](/display/pubid35773120). 40. 2022 - [Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl--cyclodextrin: A phase 1 clinical trial.](/display/pubid35672178) 2022 - [Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.](/display/pubid35637066). 40. 2022 - [Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.](/display/pubid34393017). 39. 2021 - [Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice.](/display/pubid32943267). 38. 2020 - [Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.](/display/pubid32482459). 38. 2020 - [Impact of media reports regarding influenza vaccine on obstetricians' vaccination practices.](/display/pubid32204941). 38. 2020 - [Beliefs in vaccine as causes of autism among SPARK cohort caregivers.](/display/pubid31924427). 38. 2020 - [Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity sera novel stabilized stem nanoparticle probes.](/display/pubid31735504). 38. 2019 - [Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers.](/display/pubid30962093). 37. 2019 - [Oral and kinetics among HIV-positive and HIV-negative men.](/display/pubid30940485). - [Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.](/display/pubid30087048). 36. 2018 - [In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.](/display/pubid30005946). 36. 2018 - [Post-exposure immunization by HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.](/display/pubid28807605). 35. 2017 - [Maternal Tdap vaccination and risk morbidity.](/display/pubid28552511). 35. 2017 - [Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.](/display/pubid28185743). 35. 2017 - [Intranasal hydroxypropyl--cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection.](/display/pubid27160037). 34. 2016 - [Active opioid use does not attenuate the humoral responses influenza vaccine.](/display/pubid26859239). 34. 2016 - [Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.](/display/pubid26765288). 34. 2016 - [Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City.](/display/pubid26458799). 33. 2015 - [Increasing influenza vaccination in New York City taxi drivers: A community driven approach.](/display/pubid25850021). 33. 2015 - [Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.](/display/pubid25171847). 32. 2014 - [Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events.](/display/pubid25045808). 32. 2014 - [Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations.](/display/pubid24886959). 32. 2014 - [Maternal pneumococcal capsular IgG antibodies and transfer are low South Asian HIV-infected mother-infant pairs.](/display/pubid24486350). 32. 2014 - [A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer.](/display/pubid23246260). 31. 2012 - [Opportunities and challenges of Web 2.0 for vaccination decisions.](/display/pubid22365840). 30. 2012 - [Development of a DNA vaccine targeting Merkel cell polyomavirus](/display/n2765). 30:1322-1329. 2012 - [Development of a DNA vaccine targeting Merkel cell polyomavirus](/display/n45377). 30:1322-1329. 2012 - [LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines](/display/n10356). 30:784-793. 2012 - [Risk perception and communication in vaccination decisions: a fuzzy-trace theory approach.](/display/pubid22133507). 30. 2011 - [Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection.](/display/pubid21854824). 29. 2011 - [Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.](/display/pubid21757105). 29 Suppl 2. 2011 - [Willingness of pregnant women to vaccinate themselves and their newborns with the HPV vaccine.](/display/pubid21557976). 29. 2011 - [Combination of epitope-optimized DNA vaccination and passive infusion of monoclonal antibody against HER2/neu leads to breast tumor regression in mice.](/display/pubid21435405). 29. 2011 - [Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.](/display/pubid21215829). 29. 2011 - [Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.](/display/pubid20600494). 28. 2010 - [Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.](/display/pubid20562015). 28. 2010 - [Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii.](/display/pubid20451637). 28. 2010 - [Echinacea purpurea aerial extract alters course of influenza infection in mice.](/display/pubid20382242). 28. 2010 - [Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.](/display/pubid19567243). 27. 2009 - [Development of effective vaccines for old mice in a tumor model.](/display/pubid19103244). 27. 2008 - [Evaluation of widely consumed botanicals as immunological adjuvants.](/display/pubid18640165). 26. 2008 - [CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.](/display/pubid18562053). 26. 2008 - [Hepatitis C glycoprotein immunization of rodents elicits cross-reactive antibodies.](/display/pubid17919789). 25. 2007 - [Immunological validation EpitOptimizer program for streamlined design of heteroclitic epitopes.](/display/pubid17570567). 25. 2007 - [Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies.](/display/pubid17537555). 25. 2007 - [Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.](/display/pubid16188351). 24. 2005 - [A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate given semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21.](/display/pubid15837210). 23. 2005 - [A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside.](/display/pubid15246627). 22. 2004 - [CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.](/display/pubid15068853). 22. 2004 - [Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice.](/display/pubid12744904). 21. 2003 - [The role of lipopolysaccharide in T-cell responses following DNA vaccination.](/display/pubid12615452). 21. 2003 - [Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies.](/display/pubid12034098). 20. 2002 - [Pertussis immunization in HIV-1-infected infants: a model to assess the effects of repeated T cell-dependent antigen administrations on HIV-1 progression. Italian Register for HIV infection in children.](/display/pubid10649621). 18. 2000 - [CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.](/display/pubid9364682). 15. 1997 - [Cytotoxic T cell induction with ratchet libraries.](/display/pubid9032897). 14. [Synthetic in microparticles can elicit cytotoxic T cell activity.](/display/pubid9014294). 14. 1996 - [Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.](/display/pubid8735553). 14. 1996 - [Relation of chronic disease and immune response to influenza vaccine in the elderly.](/display/pubid2815966). 7. 1989 - [Response to Donahue et al. 2017 in press article.](/display/pubid29306504). 36. 2018 - [Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing World Health Organization--Organisation Mondiale de la Sant\u00e9, 2003 at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.](/display/pubid32826103) 2020 - [Rising rates of vaccine exemptions: problems with current policy and more promising remedies.](/display/pubid24530934) 2014 Identity ISO Abbreviation Linking ISSN International Standard Serial Number (ISSN) "}